BSE: LUPIN - Lupin Limited

Rentabilität für sechs Monate: -9.06%
Dividendenrendite: +0.25%

Aktionsplan Lupin Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Lupin Limited

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs).

weitere details
The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

ISIN INE326A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.2475
Дивиденд ао 8
Сайт https://www.lupin.com
Цена ао 2058
Preisänderung pro Tag: -1.84% (2058)
Preisänderung pro Woche: -3.1% (2084.75)
Preisänderung pro Monat: +6.61% (1894.95)
Preisänderung über 3 Monate: -7.4% (2181.6)
Preisänderung über sechs Monate: -9.06% (2221.5)
Preisänderung pro Jahr: +26.4% (1598.2)
Preisänderung über 3 Jahre: +160.78% (774.65)
Preisänderung über 5 Jahre: +187.28% (703.2)
Preisänderung seit Jahresbeginn: -14.07% (2350.95)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 3.73 5
P/BV 5.1 3
P/E 38.27 4
EV/EBITDA 17.69 6
Gesamt: 6.25

Effizienz

Name Bedeutung Grad
ROA, % 8.15 3
ROE, % 14.31 4
Gesamt: 2.33

Dividenden

Name Bedeutung Grad
Div yield, % 0.2475 0.63
DSI 0.9286 9.29
Gesamt: 3.84

Pflicht

Name Bedeutung Grad
Debt/EBITDA 2.37 6
Gesamt: 8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 27.85 4
Rentabilität Ebitda, % -34.8 0
Rentabilität EPS, % -799.78 0
Gesamt: 2.8
Weitere Details

ETFAktie, %Rentabilität für das Jahr, %Dividenden, %
VictoryShares Emerging Markets Value Momentum ETF 1.19724 13.66 4.52229
Rayliant Quantamental Emerging Market ex-China Equity ETF 0.74367 20.79 2.96779
Matthews Emerging Markets Equity Active ETF 0.64974 23.55 2.50435
Invesco S&P Emerging Markets Momentum ETF 0.55248 18.98 2.50979
iShares MSCI Emerging Markets Min Vol Factor ETF 0.51836 6.61 2.95411
FlexShares Emerging Markets Quality Low Volatility Index Fund 0.37758 15.93 3.30543
iShares MSCI India ETF 0.36205 3.5 1.24292
Franklin FTSE India ETF 0.33907 20.52 1.25133
Hartford Multifactor Emerging Markets ETF 0.28003 11.21 5.04734
WisdomTree Emerging Markets Multifactor Fund 0.27675 16.97 3.61297
First Trust Emerging Markets Small Cap AlphaDEX Fund 0.27376 1061.14 2.70393
Avantis Responsible Emerging Markets Equity ETF 0.2107 17.6 3.1719
SPDR MSCI Emerging Markets StrategicFactors ETF 0.17152 8.65 3.55491
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.16577 2.43 4.35382
WisdomTree India Earnings Fund 0.1583 5.23 1.65591
iShares MSCI BIC ETF 0.1509 14.55 2.77084
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.12948 9.13 3.47133
Dimensional Emerging Markets Value ETF 0.11875 17.07 4.19508
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.11342 14.02 2.84808
Avantis Emerging Markets Equity ETF 0.09931 8.77 3.60513
iShares MSCI Emerging Markets Asia ETF 0.09395 13.87 2.40119
WisdomTree Emerging Markets Efficient Core Fund 0.09356 17.03 3.08497
Franklin FTSE Asia ex Japan ETF 0.08263 14.43 2.66768
SPDR Portfolio Emerging Markets ETF 0.08138 11.59 3.1879
Dimensional Emerging Markets Core Equity 2 ETF 0.07322 15.96 3.34087
John Hancock Multifactor Emerging Markets ETF 0.0722 4.68 3.42078
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.07137 15.84 3.04307
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.05053 12.46 3.59676
SPDR MSCI ACWI ex-US ETF 0.04459 7.85 3.3217
Dimensional World ex U.S. Core Equity 2 ETF 0.03774 13.06 3.62488
Xtrackers MSCI All World ex US Hedged Equity ETF 0.02276 18.18 3.26685
iShares Core MSCI Total International Stock ETF 0.02016 6.4 3.25258
Vanguard ESG International Stock ETF 0.02 6.39 3.07501
iShares MSCI ACWI ETF 0.00538 -19.68 2.10908
0.2242.63.11

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Ms. Vinita D. Gupta CEO & Executive Director 109.2M 1968 (57 Jahre)
Mr. Nilesh Deshbandhu Gupta MD & Executive Director 49.6M 1974 (51 Jahr)
Mr. Ramesh Swaminathan Global CFO, CRO, Head of Corporate Affairs & Executive Director 66.86M 1966 (59 Jahre)
Mr. Christoph Funke Chief Technical Operations Officer
Mr. Sreeji Gopinathan Chief Information Officer
Dr. Shahin Fesharaki Global Chief Scientific Officer
Mr. Ravi Agrawal Sr. Vice President of Investor Relations and M&A
Dr. Sofia Mumtaz President of Legal and Compliance of Australia, Japan & Canada Business
Mr. Amit Kumar Gupta Company Secretary & Compliance Officer
Ms. Rajalakshmi Azariah Vice President & Global Head of Corporate Communications

Adresse: India, Mumbai, Kalpataru Inspire - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.lupin.com